EQS-News : Medacta Adds the MyHip Planner and the MyHip Verifier Tools to its Personalized Medicine Solutions for Hip Replacement

EQS Group-News: Medacta Group SA / Key word(s): Product Launch 
Medacta Adds the MyHip Planner and the MyHip Verifier Tools to its Personalized Medicine Solutions for Hip Replacement 
2021-02-15 / 19:00 
=---------------------------------------------------------------------------------------------------------------------- 
Media release 
Medacta Adds the MyHip^(R) Planner and the MyHip^(R) Verifier Tools to its Personalized Medicine Solutions for Hip 
Replacement 
CASTEL SAN PIETRO, 15 February 2021 - Medacta is proud to announce that it has received clearance from the U.S. Food 
and Drug Administration (FDA) for its MyHip^(R) Planner and MyHip^(R) Verifier, after recently receiving CE marking and 
approval from Australia's Therapeutic Goods Administration (TGA) and from the Japanese Ministry of Health, Labour and 
Welfare (MHLW). These two promising innovative technologies will be introduced into all markets in which Medacta 
operates in the upcoming months. 
MyHip Planner and MyHip Verifier are two personalized solutions which are intended to be used in primary total hip 
replacement for 3D pre-operative planning and intra-operative verification. Designed to predict and minimize surgical 
complexity, as well as to improve overall surgical outcomes and patient satisfaction, these applications can be used as 
stand-alone tools or together, and are intended to deliver a personalized approach to total hip arthroplasty (THA), 
optimizing the surgical experience. 
MyHip Planner is a surgeon-operated CT-based software which allows the user to create a patient-specific pre-operative 
3D plan. Through an automatic and precise 3D reconstruction of the patient's anatomy and the real time post-operative 
dynamic simulation of the range of motion in everyday activities based on an advanced impingement detection algorithm, 
this software allows the surgeon to tailor implant choice and position to the patient's anatomy, hip joint 
biomechanics, and functional needs. MyHip Planner eases and empowers the critical decision-making process in defining 
the optimal surgical strategy for each patient. A streamlined protocol assists the surgeon when executing a 3D 
anatomical assessment of the anatomy and planning for the optimal implant and position within the hip joint. This helps 
anticipate potential intra-operative complications, such as femoral fracture and leg length inequality, or detect 
potential risks of implant failures, such as impingement, reduced range of motion (ROM) and overall joint instability. 
When talking about MyHip Planner, Dr Lachlan Milne (MBBS FRACS), orthopaedic surgeon at Hollywood Consulting Centre in 
Nedlands, Western Australia, and member of the expert surgeon panel that collaborated with Medacta to develop the MyHip 
Planner and MyHip Verifier platforms, says: "MyHip Planner has revolutionized my approach to hip arthroplasty, by 
allowing a personalized solution to be created for each individual patient based on their anatomy, in order to suit 
their functional demands. This innovative platform has improved the accuracy and efficiency of surgery and has become 
an essential part of my practice." 
MyHip Verifier is an easy-to-use, non-invasive surgical platform that uses intra-operative fluoroscopic images to 
assist the surgeon in verifying patient-specific implant positioning. Engineered to integrate seamlessly into the 
surgeons' existing workflow and preserving operating room efficiency, MyHip Verifier empowers intra-operative 
fluoroscopy by providing a real time numerical evaluation of the actual influence of implant positioning on the 
patient's anatomy. By allowing the evaluation of crucial parameters for patient satisfaction, such as leg length, 
offset and cup position, MyHip Verifier enables physicians to make decisions about component positioning, potentially 
improving THA clinical outcomes and long-term patient well-being. MyHip Verifier may lead to increased confidence and 
reproducibility, while potentially reducing surgical outliers and improving surgical outcomes, particularly with 
respect to common complications, such as leg length discrepancy, unusual hip joint laxity, and dislocation. 
"MyHip Verifier is a time-neutral tool allowing an accurate intraoperative analysis of the surgical reconstruction. 
When combined with MyHip Planner, it is a powerful tool to ensure that the plan has been successfully executed, 
providing optimal surgical outcomes for my hip replacement patients," concludes Dr Milne. 
MyHip Planner and MyHip Verifier are part of the MySolutions Platform, Medacta's personalized medicine offering, which 
also includes MyHip 3D printed patient-specific guides, POP^(R) - Patient Optimized Pathway and MyClinical Data. 
Together with a comprehensive implant portfolio, the AMIS^(R) Experience, and a dedicated medical education program 
organized by Medacta's M.O.R.E. Institute, MyHip Planner and MyHip Verifier empowers Medacta's holistic approach to 
personalized medicine in hip arthroplasty. 
Francesco Siccardi, CEO of Medacta says: "With our new MyHip Planner and MyHip Verifier, Medacta is enriching its 
integrated digital ecosystem, according to our holistic approach to personalized medicine. Our goal is to bring value 
at every step throughout the entire treatment journey, while supporting surgeons to improve patient outcomes and 
maximizing value for the healthcare system. Our ecosystem of personalized and highly technological solutions will be 
soon enhanced with our new NextAR^TM augmented reality-based surgical platform, which we have recently launched for 
total knee arthroplasty, and which we are working to integrate in our hip portfolio." 
To learn more about Medacta's MyHip Planner and MyHip Verifier tools, please visit https://www.medacta.com/EN/ 
home-myhip-planner-verifier 
Contact 
Medacta International SA 
Gianluca Olgiati 
Senior Director Global Marketing 
Phone: [phone] 
[e-mail] 
About Medacta 
Medacta is an international company specialized in the design and production of innovative orthopaedic products and the 
development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint 
replacement, spine surgery, and sports medicine. Medacta is a pioneer in developing new offerings on the basis of 
minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (AMIS) technique for hip 
replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to 
develop the sophisticated MySolutions technology, which offers surgeons highly personalized pre-operative planning and 
implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in 
hip, knee, shoulder and spine procedures. 
=---------------------------------------------------------------------------------------------------------------------- 
End of Media Release 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Medacta Group SA 
              Strada Regina 
              6874 Castel San Pietro 
              Switzerland 
Phone:        [phone] 
E-mail:       [e-mail],[e-mail] 
Internet:     www.medacta.com 
ISIN:         CH0468525222 
Listed:       SIX Swiss Exchange 
EQS News ID:  1167845 
 
End of News   EQS Group News Service 
=------------ 

1167845 2021-02-15

(END) Dow Jones Newswires

February 15, 2021 13:02 ET (18:02 GMT)